Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1990 Aug 15;270(1):269–271. doi: 10.1042/bj2700269

Transforming growth factor beta 2 differentially modulates interleukin-1 beta- and tumour-necrosis-factor-alpha-stimulated phospholipase A2 and prostaglandin E2 synthesis in rat renal mesangial cells.

J Pfeilschifter 1, W Pignat 1, J Leighton 1, F Märki 1, K Vosbeck 1, S Alkan 1
PMCID: PMC1131710  PMID: 2396988

Abstract

Treatment of rat glomerular mesangial cells with transforming growth factor beta 2 (TGF beta 2) stimulates prostaglandin E2 (PGE2) synthesis. Actinomycin D, cycloheximide and diclofenac attenuate the TGF beta 2-induced PGE2 formation. As shown previously, two proinflammatory cytokines, interleukin 1 beta (IL-1 beta) and tumour necrosis factor alpha (TNF alpha), are potent stimuli for PGE2 and phospholipase A2 secretion from mesangial cells. We report here that, whereas TGF beta 2 potentiates the IL-1 beta- and TNF alpha-evoked PGE2 production, it strongly inhibits the phospholipase A2 secretion induced by both cytokines. In addition, the inhibitory effect of TGF beta 2 on phospholipase A2 secretion is not due to the augmented PGE2 formation.

Full text

PDF
269

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alkan S. S. Antigen-induced proliferation assay for mouse T lymphocytes. Response to a monovalent antigen. Eur J Immunol. 1978 Feb;8(2):112–118. doi: 10.1002/eji.1830080208. [DOI] [PubMed] [Google Scholar]
  2. Assoian R. K., Komoriya A., Meyers C. A., Miller D. M., Sporn M. B. Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization. J Biol Chem. 1983 Jun 10;258(11):7155–7160. [PubMed] [Google Scholar]
  3. Baud L., Perez J., Friedlander G., Ardaillou R. Tumor necrosis factor stimulates prostaglandin production and cyclic AMP levels in rat cultured mesangial cells. FEBS Lett. 1988 Oct 24;239(1):50–54. doi: 10.1016/0014-5793(88)80543-x. [DOI] [PubMed] [Google Scholar]
  4. Chandrasekhar S., Harvey A. K. Transforming growth factor-beta is a potent inhibitor of IL-1 induced protease activity and cartilage proteoglycan degradation. Biochem Biophys Res Commun. 1988 Dec 30;157(3):1352–1359. doi: 10.1016/s0006-291x(88)81024-6. [DOI] [PubMed] [Google Scholar]
  5. DULBECCO R., VOGT M. Plaque formation and isolation of pure lines with poliomyelitis viruses. J Exp Med. 1954 Feb;99(2):167–182. doi: 10.1084/jem.99.2.167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Diaz A., Varga J., Jimenez S. A. Transforming growth factor-beta stimulation of lung fibroblast prostaglandin E2 production. J Biol Chem. 1989 Jul 15;264(20):11554–11557. [PubMed] [Google Scholar]
  7. Dworkin L. D., Ichikawa I., Brenner B. M. Hormonal modulation of glomerular function. Am J Physiol. 1983 Feb;244(2):F95–104. doi: 10.1152/ajprenal.1983.244.2.F95. [DOI] [PubMed] [Google Scholar]
  8. Frolik C. A., Dart L. L., Meyers C. A., Smith D. M., Sporn M. B. Purification and initial characterization of a type beta transforming growth factor from human placenta. Proc Natl Acad Sci U S A. 1983 Jun;80(12):3676–3680. doi: 10.1073/pnas.80.12.3676. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Jaffer F., Saunders C., Shultz P., Throckmorton D., Weinshell E., Abboud H. E. Regulation of mesangial cell growth by polypeptide mitogens. Inhibitory role of transforming growth factor beta. Am J Pathol. 1989 Aug;135(2):261–269. [PMC free article] [PubMed] [Google Scholar]
  10. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  11. Lovett D. H., Resch K., Gemsa D. Interleukin I and the glomerular mesangium. II. Monokine stimulation of mesangial cell prostanoid secretion. Am J Pathol. 1987 Dec;129(3):543–551. [PMC free article] [PubMed] [Google Scholar]
  12. MacKay K., Striker L. J., Stauffer J. W., Doi T., Agodoa L. Y., Striker G. E. Transforming growth factor-beta. Murine glomerular receptors and responses of isolated glomerular cells. J Clin Invest. 1989 Apr;83(4):1160–1167. doi: 10.1172/JCI113996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Märki F., Franson R. Endogenous suppression of neutral-active and calcium-dependent phospholipase A2 in human polymorphonuclear leukocytes. Biochim Biophys Acta. 1986 Nov 14;879(2):149–156. doi: 10.1016/0005-2760(86)90097-4. [DOI] [PubMed] [Google Scholar]
  14. Pfeilschifter J., Kurtz A., Bauer C. Activation of phospholipase C and prostaglandin synthesis by [arginine]vasopressin in cultures. Biochem J. 1984 Nov 1;223(3):855–859. doi: 10.1042/bj2230855. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Pfeilschifter J., Pignat W., Vosbeck K., Märki F. Interleukin 1 and tumor necrosis factor synergistically stimulate prostaglandin synthesis and phospholipase A2 release from rat renal mesangial cells. Biochem Biophys Res Commun. 1989 Mar 15;159(2):385–394. doi: 10.1016/0006-291x(89)90003-x. [DOI] [PubMed] [Google Scholar]
  16. Pruzanski W., Vadas P., Fornasier V. Inflammatory effect of intradermal administration of soluble phospholipase A2 in rabbits. J Invest Dermatol. 1986 Apr;86(4):380–383. doi: 10.1111/1523-1747.ep12285639. [DOI] [PubMed] [Google Scholar]
  17. Rahman M. A., Stork J. E., Dunn M. J. The roles of eicosanoids in experimental glomerulonephritis. Kidney Int Suppl. 1987 Oct;22:S40–S48. [PubMed] [Google Scholar]
  18. Roberts A. B., Anzano M. A., Meyers C. A., Wideman J., Blacher R., Pan Y. C., Stein S., Lehrman S. R., Smith J. M., Lamb L. C. Purification and properties of a type beta transforming growth factor from bovine kidney. Biochemistry. 1983 Dec 6;22(25):5692–5698. doi: 10.1021/bi00294a002. [DOI] [PubMed] [Google Scholar]
  19. Taylor D. J., Feldmann M., Evanson J. M., Woolley D. E. Comparative and combined effects of transforming growth factors alpha and beta, interleukin-1 and interferon-gamma on rheumatoid synovial cell proliferation, glycolysis and prostaglandin E production. Rheumatol Int. 1989;9(2):65–70. doi: 10.1007/BF00270247. [DOI] [PubMed] [Google Scholar]
  20. Topley N., Floege J., Wessel K., Hass R., Radeke H. H., Kaever V., Resch K. Prostaglandin E2 production is synergistically increased in cultured human glomerular mesangial cells by combinations of IL-1 and tumor necrosis factor-alpha 1. J Immunol. 1989 Sep 15;143(6):1989–1995. [PubMed] [Google Scholar]
  21. Travo P., Weber K., Osborn M. Co-existence of vimentin and desmin type intermediate filaments in a subpopulation of adult rat vascular smooth muscle cells growing in primary culture. Exp Cell Res. 1982 May;139(1):87–94. doi: 10.1016/0014-4827(82)90321-4. [DOI] [PubMed] [Google Scholar]
  22. Vadas P., Pruzanski W., Kim J., Fornasier V. The proinflammatory effect of intra-articular injection of soluble human and venom phospholipase A2. Am J Pathol. 1989 Apr;134(4):807–811. [PMC free article] [PubMed] [Google Scholar]
  23. Wahl S. M., McCartney-Francis N., Mergenhagen S. E. Inflammatory and immunomodulatory roles of TGF-beta. Immunol Today. 1989 Aug;10(8):258–261. doi: 10.1016/0167-5699(89)90136-9. [DOI] [PubMed] [Google Scholar]
  24. Wardle E. N. Cells and mediators in glomerulonephritis. Nephron. 1988;49(4):265–276. doi: 10.1159/000185074. [DOI] [PubMed] [Google Scholar]
  25. Yamashita W., MacCarthy E. P., Hsu A., Gartside P. S., Ooi B. S. The effect of transforming growth factor-beta on mouse mesangial cell proliferation. Clin Exp Immunol. 1989 Aug;77(2):285–288. [PMC free article] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES